A lot is riding on the upcoming results for Compass Pathways’ psilocybin-based depression treatment.
Set to be released by the end of this quarter, the data will reveal results from what Compass calls the “largest randomized, controlled, double-blind…
Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:
Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
